ICIQ-UI SF score reduction after 3 months’ treatment; incontinent users who responded to the 3-month follow-up
| Score at baseline, mean (SD) | Score at 3-month follow-up, mean (SD) | Difference (95% CI) | P value* | |
| All incontinent users (n=2163) | 8.11 (3.87) | 6.80 (3.97) | 1.31 (1.19 to 1.44) | <0.001 |
| Symptom severity | ||||
| Slight (n=689) | 4.18 (0.74) | 3.94 (2.54) | 0.24 (0.06 to 0.42) | 0.010 |
| Moderate (n=1145) | 8.50 (1.97) | 7.09 (3.10) | 1.41 (1.24 to 1.59) | <0.001 |
| Severe/very severe (n=329) | 14.98 (1.93) | 11.76 (3.80) | 3.23 (2.85 to 3.61) | <0.001 |
| Type of incontinence | ||||
| Stress incontinence (n=1196) | 7.66 (3.70) | 6.38 (3.78) | 1.28 (1.11 to 1.45) | <0.001 |
| Urgency incontinence (n=263) | 7.59 (3.88) | 6.26 (4.14) | 1.33 (0.95 to 1.71) | <0.001 |
| Mixed incontinence (n=632) | 9.20 (3.96) | 7.86 (4.02) | 1.34 (1.09 to 1.58) | <0.001 |
| Other (n=72) | 7.89 (4.01) | 6.26 (4.14) | 1.63 (0.76 to 2.50) | <0.001 |
*Analysed with paired t-test.
ICIQ-UI SF, International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form.